Helén Tuvesson

Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR‐215757), a new quinoline‐3‐carboxamide derivative: Studies in lupus‐prone mice and a multicenter, randomized, double‐blind, placebo‐controlled, repeat‐dose, dose‐ranging study in patients with systemic lupus erythematosus

Anders Bengtsson, Gunnar Sturfelt, Christian Lood et al. · Arthritis & Rheumatism · 2011 · 124 citations

Medicine, Pharmacokinetics, Pharmacology +11

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer

Andrew J. Armstrong, Aseem Anand, Lars Edenbrandt et al. · JAMA Oncology · 2018 · 102 citations · Full text

Medicine, Oncology, Radiology +17

Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer

Cora N. Sternberg, Andrew J. Armstrong, Siobhan Ng et al. · Journal of Clinical Oncology · 2016 · 101 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis

Martin Stenström, Helén Nyhlén, Marie Törngren et al. · Journal of Dermatological Science · 2016 · 52 citations · Full text

Life Sciences, Immunology, Pharmacology +17

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

Roger Hesselstrand, Jörg H. W. Distler, Gabriela Riemekasten et al. · Arthritis Research & Therapy · 2021 · 43 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17